Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Yu

Showing results (261-270 of 282) with videos related to

Pageof 29
Sort By:
Neuro-Oncology|November 5, 2025
Multicenter Randomized Phase II Study of R-MPV-A Chemoimmunotherapy With or Without Low-Dose Whole-Brain Radiotherapy for Newly-Diagnosed Primary CNS LymphomaAntonio Omuro, Lisa M DeAngelis, Mei-Yin C Polley, et al.
Acta Cardiologica Sinica|November 25, 2020
2020 Consensus Statement of the Taiwan Hypertension Society and the Taiwan Society of Cardiology on Home Blood Pressure Monitoring for the Management of Arterial HypertensionHung-Ju Lin, Tzung-Dau Wang, Michael Yu-Chih Chen, et al.
International Journal of Environmental Research and Public Health|September 23, 2022
COVID-19 Vaccinating Russian Medical Students-Challenges and Solutions: A Cross-Sectional StudyOlesya V Kytko, Yuriy L Vasil'ev, Sergey S Dydykin, et al.
Journal for Immunotherapy of Cancer|April 28, 2025
Nivolumab and stereotactic radiosurgery for patients with breast cancer brain metastases: long-term results and biomarker analysis from a non-randomized, open-label, phase Ib studyKamran A Ahmed, Younchul Kim, Sungjune Kim, et al.
Neuro-Oncology|November 11, 2020
Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I studySolmaz Sahebjam, Peter A Forsyth, Nam D Tran, et al.
Advances in Radiation Oncology|December 22, 2021
Nivolumab and Stereotactic Radiosurgery for Patients With Breast Cancer Brain Metastases: A Nonrandomized, Open-Label Phase 1b StudyKamran A Ahmed, Youngchul Kim, John A Arrington, et al.
International Journal of Radiation Oncology, Biology, Physics|April 7, 2020
Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424Barbara J Fisher, Stephanie L Pugh, David R Macdonald, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 19, 2007
NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancerDonald A Podoloff, Ranjana H Advani, Craig Allred, et al.
JCO Precision Oncology|September 30, 2021
Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II GliomaJessica L Fleming, Stephanie L Pugh, Barbara J Fisher, et al.
Nature Communications|January 29, 2025
Intricacies of human-AI interaction in dynamic decision-making for precision oncologyDipesh Niraula, Kyle C Cuneo, Ivo D Dinov, et al.
Pageof 29

Showing results (261-270 of 282) with videos related to

Sort By:
Pageof 29
Neuro-Oncology|November 5, 2025
Multicenter Randomized Phase II Study of R-MPV-A Chemoimmunotherapy With or Without Low-Dose Whole-Brain Radiotherapy for Newly-Diagnosed Primary CNS LymphomaAntonio Omuro, Lisa M DeAngelis, Mei-Yin C Polley, et al.
Acta Cardiologica Sinica|November 25, 2020
2020 Consensus Statement of the Taiwan Hypertension Society and the Taiwan Society of Cardiology on Home Blood Pressure Monitoring for the Management of Arterial HypertensionHung-Ju Lin, Tzung-Dau Wang, Michael Yu-Chih Chen, et al.
International Journal of Environmental Research and Public Health|September 23, 2022
COVID-19 Vaccinating Russian Medical Students-Challenges and Solutions: A Cross-Sectional StudyOlesya V Kytko, Yuriy L Vasil'ev, Sergey S Dydykin, et al.
Journal for Immunotherapy of Cancer|April 28, 2025
Nivolumab and stereotactic radiosurgery for patients with breast cancer brain metastases: long-term results and biomarker analysis from a non-randomized, open-label, phase Ib studyKamran A Ahmed, Younchul Kim, Sungjune Kim, et al.
Neuro-Oncology|November 11, 2020
Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I studySolmaz Sahebjam, Peter A Forsyth, Nam D Tran, et al.
Advances in Radiation Oncology|December 22, 2021
Nivolumab and Stereotactic Radiosurgery for Patients With Breast Cancer Brain Metastases: A Nonrandomized, Open-Label Phase 1b StudyKamran A Ahmed, Youngchul Kim, John A Arrington, et al.
International Journal of Radiation Oncology, Biology, Physics|April 7, 2020
Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424Barbara J Fisher, Stephanie L Pugh, David R Macdonald, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 19, 2007
NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancerDonald A Podoloff, Ranjana H Advani, Craig Allred, et al.
JCO Precision Oncology|September 30, 2021
Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II GliomaJessica L Fleming, Stephanie L Pugh, Barbara J Fisher, et al.
Nature Communications|January 29, 2025
Intricacies of human-AI interaction in dynamic decision-making for precision oncologyDipesh Niraula, Kyle C Cuneo, Ivo D Dinov, et al.
Pageof 29